Inflazome Alternatives & Competitors
12 companies similar to Inflazome — Inflazome develops drugs to block inflammasome signals, reducing unwanted inflam...
Companies similar to Inflazome
NodThera
Treating chronic disease by targeting inflammation at its source
Philadelphia, United Stat...
Azome Therapeutics
Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases
Coley Pharmaceutical Group
Empowering the immune system to conquer illnesses and boost vaccine efficacy.
Rival Readout
Competing with Inflazome? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Elicio Therapeutics
Lymph-Node Targeted Immunotherapies
Boston, United States
Emergo Therapeutics
Bringing the Immune Response Back into Balance
Durham, United States
Telormedix
Pioneering targeted immunity for cancer and autoimmune disease treatment through innovativ...
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on th...
Invirsa, Inc
A Phase 3 ready clinical-stage ophthalmology company pioneering the world's first DNA Repa...
Columbus, United States
CytoAgents, Inc
Calming the Cytokine Storm, Rebalancing the Immune System. Accessible treatment for mult...
Pittsburgh, United States
Allakos Inc
Antibody-based therapeutics to treat various allergies and diseases
Redwood City, United Stat...
Nuvig Therapeutics Inc.
Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases
Menlo Park, United States
About Inflazome
Inflazome is a biopharmaceutical startup founded in 2016 that is devoted to developing groundbreaking drugs aimed at blocking inflammasome signals, thus reducing unwanted inflammation associated with various diseases. The company's mission is reflected in their slogan: "Inflazome develops drugs to block inflammasome si...
Inflammasome Inhibitors, Biological Target, Innate Immune Response, Disease Treatment, Immune System Modulation, Drug Development, Inflammation, Immune Response Regulation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Inflazome: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Inflazome on 11 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
